Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026)
Cartesian Therapeutics' EBITDA came in at -$28.38 million for Q2 2026, compared with -$21.22 million a year earlier.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cartesian Therapeutics reported EBITDA of -$152.75 million; for FY2025, it came in at -$140.45 million.
- Going back by year, EBITDA was -$42.75 million in FY2024, -$85.57 million in FY2023, $15.83 million in FY2022 and -$3.35 million in FY2021.
- The five-year range for quarterly EBITDA is -$78.03 million (Q4 2025) to $14.21 million (Q2 2022).
- Business Quant data shows RNAC's EBITDA at -$25.88 million (Q1 2026), -$78.03 million (Q4 2025) and -$20.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Cartesian Therapeutics | 188.59 Mn | -346.18 Mn | - | -28.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.13 Mn |
| Mar 31, 2026 | -25.65 Mn |
| Dec 31, 2025 | -77.82 Mn |
| Sep 30, 2025 | -20.27 Mn |
| Jun 30, 2025 | -21.04 Mn |
| Mar 31, 2025 | -20.55 Mn |
| Dec 31, 2024 | -25.57 Mn |
| Sep 30, 2024 | -16.64 Mn |
| Jun 30, 2024 | 14.55 Mn |
| Mar 31, 2024 | -12.65 Mn |
| Dec 31, 2023 | -35.58 Mn |
| Sep 30, 2023 | -12.44 Mn |
| Jun 30, 2023 | -18.04 Mn |
| Mar 31, 2023 | -17.76 Mn |
| Dec 31, 2022 | -7.85 Mn |
| Sep 30, 2022 | -910,000.00 |
| Jun 30, 2022 | 14.50 Mn |
| Mar 31, 2022 | 11.42 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | -1.35 Mn |
API Access
Cartesian Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();